期刊文献+

基于指南之糖尿病肾病的诊疗 被引量:22

Diagnosis and treatment of diabetic nephropathy based on the guide
暂未订购
导出
摘要 糖尿病肾病(DN)是糖尿病主要的慢性并发症之一,也是导致终末期肾病的主要原因之一。早期诊断和治疗DN对于改善疾病的预后,提高糖尿病患者的生活质量,延长生存周期有着非常重大的意义。本文结合2010年我国2型糖尿病防治指南,介绍DN的发病机制,病理特点,筛查诊断以及治疗的方法。 Diabetic nephropathy is one of the major chronic complications of diabetes, and is also one of the main causes of the end stage renal disease. Early diagnose and treatment of DP has great significance in improving the prognosis of diseases, enhancing the life quality of the diabetic patients and extending their life cycle. This article introduces the pathogenesis, screening, diagnosis and treatment methods for DN combining the 2010 guide of type 2 diabetes prevention of our country.
作者 卢叶 李海明
出处 《上海医药》 CAS 2013年第18期6-9,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 糖尿病肾病 指南 蛋白尿 diabetic nephropathy guidance proteinuria
  • 相关文献

参考文献12

  • 1Yang W, Lu J, Weng J. Prevalence of diabetes among men and women in China[J]. New Eng J Med, 2010, 362(12): 1090- 1101.
  • 2王海燕.肾脏病学[M].2版.北京:人民卫生出版社,2008:2331-2332.
  • 3Adler AI, Stevens R J, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)[J]. Kidney Int, 2003, 63(1): 225-232.
  • 4Sonme ZK, Eskisar AO, Demir D, et al. Increased urinary album inexcretion rates can be a marker of coexisting coronary artery disease in patients with peripheral arterial disease[J]. Angiology, 2006, 57(1): 15-20.
  • 5Cafi6n Barroso L, Diaz Herrera N, Calvo Hueros JI, et al. Incidence of cardiovascular disease and validity of equations of coronary risk in diabetic patients with metabolic syndrome[J]. Med Clin(Barc), 2007, 128(14): 529-535.
  • 6Yamagishi S, Fukami K, Ueda S, et al. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention[J]. Curr ]Drug Targets, 2007, 8(8): 952-959.
  • 7Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes[J]. Diabetes Care, 2004, 27(Suppl 1): S79-831.
  • 8Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study[J]. JAMA, 2003, 290(16): 2159-2167.
  • 9Rodby RA, Rohde RD, Clarke WR, et al. The Irbesartan type diabetic nephropathy trial study design and baseline patient chara,cteristics.For the Collaborative Study Group[J]. Nephrol Dial Transplant, 2000, 15(4): 487-497.
  • 10Brenner BM, Cooper ME, de Zeeuw D, et al. Effets of losartan on renal and cardiovascular outcomes in patients with type 2 diabetbic nephropathy[J]. N Engl J Med, 2001, 345(12): 861-869.

共引文献14

同被引文献225

引证文献22

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部